Postvaccination COVID‐19‐related mortality in patients with cirrhosis: Who is the culprit?
Zhihui Duan – 4 September 2022
Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis
Jana Knorr, Benedikt Kaufmann, Maria Eugenia Inzaugarat, Theresa Maria Holtmann, Lukas Geisler, Jana Hundertmark, Marlene Sophia Kohlhepp, Laela M. Boosheri, Daisy R. Chilin‐Fuentes, Amanda Birmingham, Kathleen M. Fisch, Joel D. Schilling, Sven H. Loosen, Christian Trautwein, Christoph Roderburg, Münevver Demir, Frank Tacke, Hal M. Hoffman, Ariel E. Feldstein, Alexander Wree – 3 September 2022
Single‐cell transcriptomics uncovers cellular architecture and developmental trajectories in hepatoblastoma
Hongting Huang, Liang Wu, Li Lu, Zijie Zhang, Bijun Qiu, Jialin Mo, Yi Luo, Zhifeng Xi, Mingxuan Feng, Ping Wan, Jianjun Zhu, Dingye Yu, Wei Wu, Kezhe Tan, Jiangbin Liu, Qingfeng Sheng, Ting Xu, Jinyan Huang, Zhibao Lv, Yujie Tang, Qiang Xia – 3 September 2022
A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation
Mikal Jacob Hole, Kristin Kaasen Jørgensen, Kristian Holm, Peder R. Braadland, Malin Holm Meyer‐Myklestad, Asle Wilhelm Medhus, Dag Henrik Reikvam, Alexandra Götz, Krzysztof Grzyb, Kirsten Muri Boberg, Tom Hemming Karlsen, Martin Kummen, Johannes R. Hov – 2 September 2022
Identification of novel neutralizing determinants for protection against HCV
Garazi P. Alzua, Anne F. Pihl, Anna Offersgaard, Rodrigo Velázquez‐Moctezuma, Carlos R. Duarte Hernandez, Elias H. Augestad, Ulrik Fahnøe, Christian K. Mathiesen, Henrik Krarup, Mansun Law, Jannick Prentoe, Jens Bukh, Judith M. Gottwein – 2 September 2022
CAQ Corner: Technical considerations in liver transplantation (101 for hepatologists)
Julian K. Horwitz, Fady M. Kaldas – 1 September 2022
Mortality in patients with end‐stage liver disease above model for end‐stage liver disease 3.0 of 40
Branden D. Tarlow, W. Ray Kim, Ajitha Mannalithara, Paul Y. Kwo, C. Andrew Bonham, Allison Kwong – 1 September 2022
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers
Bolni Marius Nagalo, Yumei Zhou, Emilien J. Loeuillard, Chelsae Dumbauld, Oumar Barro, Natalie M. Elliott, Alexander T. Baker, Mansi Arora, James M. Bogenberger, Nathalie Meurice, Joachim Petit, Pedro Luiz Serrano Uson, Faaiq Aslam, Elizabeth Raupach, Musa Gabere, Alexei Basnakian, Camila C. Simoes, Martin J. Cannon, Steven R. Post, Kenneth Buetow, Jean Christopher Chamcheu, Michael T. Barrett, Dan G. Duda, Bertram Jacobs, Richard Vile, Michael A. Barry, Lewis R. Roberts, Sumera Ilyas, Mitesh J. Borad – 1 September 2022
Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretion
Willemien Zwol, Antoine Rimbert, Justina C. Wolters, Marieke Smit, Vincent W. Bloks, Niels J. Kloosterhuis, Nicolette C. A. Huijkman, Mirjam H. Koster, Umesh Tharehalli, Simon M. Neck, Colin Bournez, Marceline M. Fuh, Jeroen Kuipers, Sujith Rajan, Alain Bruin, Henry N. Ginsberg, Gerard J. P. Westen, M. Mahmood Hussain, Ludger Scheja, Joerg Heeren, Philip Zimmerman, Bart Sluis, Jan Albert Kuivenhoven – 1 September 2022
CAQ Corner: Technical considerations in liver transplantation (101 for hepatologists)
Julian K. Horwitz, Fady M. Kaldas – 1 September 2022